SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2ogv'

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BZF_A_TMQA170_1 (DIHYDROFOLATE REDUCTASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	ALA A 763 LEU A 910 LEU A 845 LEU A 675 ALA A 792	None	1.02A	1bzfA-2ogvA: undetectable	1bzfA-2ogvA: 19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EPB_A_9CRA165_2 (EPIDIDYMAL RETINOIC ACID-BINDING PROTEIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 7	LEU A 786 ALA A 792 PHE A 758 VAL A 762	None	0.82A	1epbA-2ogvA: undetectable	1epbA-2ogvA: 21.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_A_STIA201_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 ASP A 796	None	0.98A	1iepA-2ogvA: 32.7	1iepA-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_A_STIA201_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.90A	1iepA-2ogvA: 32.7	1iepA-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_B_STIB202_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 ASP A 796	None	0.97A	1iepB-2ogvA: 32.7	1iepB-2ogvA: 38.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MUO_A_ADNA1_1 (AURORA-RELATED KINASE 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 9	LEU A 588 GLY A 589 VAL A 596 ALA A 614 TYR A 665 LEU A 785	None	0.77A	1muoA-2ogvA: 17.0	1muoA-2ogvA: 27.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1OPJ_A_STIA3_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 ASP A 796	None	0.92A	1opjA-2ogvA: 22.0	1opjA-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1OPJ_A_STIA3_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 LEU A 785	None	0.85A	1opjA-2ogvA: 22.0	1opjA-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1OPJ_B_STIB4_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 GLY A 669 ASP A 796	None	0.91A	1opjB-2ogvA: 21.9	1opjB-2ogvA: 38.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SH9_B_RITB301_1 (POL POLYPROTEIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 8	ILE A 885 ILE A 888 GLY A 842 ILE A 843 PRO A 878	None	1.07A	1sh9A-2ogvA: undetectable	1sh9A-2ogvA: 15.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T46_A_STIA3_1 (HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	10 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLU A 633 VAL A 647 THR A 663 GLY A 669 LEU A 785 ASP A 796	None	0.68A	1t46A-2ogvA: 26.9	1t46A-2ogvA: 68.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T46_A_STIA3_2 (HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 7	VAL A 661 TYR A 665 CYH A 666 CYH A 774 ARG A 777	None	1.08A	1t46A-2ogvA: 26.9	1t46A-2ogvA: 68.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TYR_B_9CRB130_1 (TRANSTHYRETIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 7	LEU A 649 THR A 654 ALA A 652 VAL A 659	None	0.97A	1tyrB-2ogvA: undetectable	1tyrB-2ogvA: 19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 THR A 663 CYH A 666 LEU A 769 HIS A 776 GLY A 795	None	0.52A	1uwhA-2ogvA: 27.8	1uwhA-2ogvA: 27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 THR A 663 CYH A 666 LEU A 769 HIS A 776 GLY A 795	None	0.51A	1uwhB-2ogvA: 27.5	1uwhB-2ogvA: 27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 LYS A 616 GLU A 633 LEU A 769 HIS A 776 GLY A 795	None	0.71A	1uwhB-2ogvA: 27.5	1uwhB-2ogvA: 27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 GLU A 633 THR A 663 CYH A 666 LEU A 769 HIS A 776 GLY A 795	None	0.57A	1uwjA-2ogvA: 11.4	1uwjA-2ogvA: 27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 GLU A 633 THR A 663 CYH A 666 LEU A 769 HIS A 776 GLY A 795	None	0.57A	1uwjB-2ogvA: 26.3	1uwjB-2ogvA: 27.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	MET A 637 GLY A 669 LEU A 672 ARG A 676 LEU A 785 ASP A 796	None	1.37A	1xkkA-2ogvA: 27.0	1xkkA-2ogvA: 32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	THR A 663 GLY A 669 LEU A 672 ARG A 676 LEU A 785 ASP A 796	None	0.92A	1xkkA-2ogvA: 27.0	1xkkA-2ogvA: 32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2GQG_A_1N1A501_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 GLY A 669 LEU A 785	None	0.84A	2gqgA-2ogvA: 22.7	2gqgA-2ogvA: 38.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2GQG_B_1N1B502_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 GLY A 669 LEU A 785	None	0.73A	2gqgB-2ogvA: 29.6	2gqgB-2ogvA: 38.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_A_STIA600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 ASP A 796	None	0.93A	2hyyA-2ogvA: 32.6	2hyyA-2ogvA: 37.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_A_STIA600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.85A	2hyyA-2ogvA: 32.6	2hyyA-2ogvA: 37.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_B_STIB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 ASP A 796	None	0.92A	2hyyB-2ogvA: 33.0	2hyyB-2ogvA: 37.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_B_STIB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.82A	2hyyB-2ogvA: 33.0	2hyyB-2ogvA: 37.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_C_STIC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 GLU A 633 VAL A 647 THR A 663 GLY A 669 LEU A 785 ASP A 796	None	0.80A	2hyyC-2ogvA: 32.5	2hyyC-2ogvA: 37.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_D_STID600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 ASP A 796	None	0.91A	2hyyD-2ogvA: 33.0	2hyyD-2ogvA: 37.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_D_STID600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 LEU A 785	None	0.83A	2hyyD-2ogvA: 33.0	2hyyD-2ogvA: 37.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OIQ_A_STIA1001_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	ALA A 614 GLU A 633 MET A 637 THR A 663 TYR A 665 GLY A 669 LEU A 785 ASP A 796	None	0.74A	2oiqA-2ogvA: 20.5	2oiqA-2ogvA: 34.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OIQ_A_STIA1001_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.78A	2oiqA-2ogvA: 20.5	2oiqA-2ogvA: 34.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PL0_A_STIA200_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 ASP A 796	None	0.95A	2pl0A-2ogvA: 29.7	2pl0A-2ogvA: 37.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XP2_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 9	LEU A 588 VAL A 596 ALA A 614 GLY A 669 LEU A 785 GLY A 795 ASP A 796	None	0.76A	2xp2A-2ogvA: 30.4	2xp2A-2ogvA: 36.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_C_CTCC1385_0 (TETX2 PROTEIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	ASP A 778 ARG A 782 GLY A 852 SER A 850 MET A 875	None	1.50A	2y6rC-2ogvA: undetectable	2y6rC-2ogvA: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_D_CTCD1385_0 (TETX2 PROTEIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 10	ASP A 778 ARG A 782 GLY A 852 SER A 850 MET A 875	None	1.49A	2y6rD-2ogvA: 0.0	2y6rD-2ogvA: 20.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2YFX_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 8	LEU A 588 ALA A 614 GLY A 669 LEU A 785 GLY A 795 ASP A 796	None	0.77A	2yfxA-2ogvA: 30.4	2yfxA-2ogvA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ZVA_A_1N1A513_1 (TYROSINE-PROTEIN KINASE LYN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 ALA A 614 LYS A 616 GLU A 633 MET A 637 VAL A 647 THR A 663 GLY A 669 LEU A 785	None	0.92A	2zvaA-2ogvA: 30.2	2zvaA-2ogvA: 38.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3AOX_A_EMHA901_1 (ALK TYROSINE KINASE RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 10	LEU A 588 ALA A 614 LYS A 616 VAL A 647 GLY A 669 LEU A 785	None	0.69A	3aoxA-2ogvA: 20.4	3aoxA-2ogvA: 36.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3C7Q_A_XINA1172_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 GLY A 589 GLU A 598 ALA A 614 LYS A 616 VAL A 647 CYH A 666 GLY A 669 LEU A 785	None	0.56A	3c7qA-2ogvA: 34.8	3c7qA-2ogvA: 51.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_A_NILA600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 HIS A 776 LEU A 785	None	0.72A	3cs9A-2ogvA: 32.7	3cs9A-2ogvA: 38.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_B_NILB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 HIS A 776 ASP A 796	None	0.86A	3cs9B-2ogvA: 30.5	3cs9B-2ogvA: 38.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 THR A 663 HIS A 776 ASP A 796	None	0.90A	3cs9C-2ogvA: 29.5	3cs9C-2ogvA: 38.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_D_NILD600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 HIS A 776	None	0.52A	3cs9D-2ogvA: 31.7	3cs9D-2ogvA: 38.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DAU_A_MTXA201_1 (DIHYDROFOLATE REDUCTASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	ILE A 794 ASP A 837 ALA A 770 ILE A 636 LEU A 640	None	1.10A	3dauA-2ogvA: undetectable	3dauA-2ogvA: 17.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FUP_B_MI1B1_1 (TYROSINE-PROTEIN KINASE JAK2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 GLY A 589 VAL A 596 ALA A 614 VAL A 647 TYR A 665 LEU A 785	None	0.50A	3fupB-2ogvA: 28.0	3fupB-2ogvA: 34.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G0E_A_B49A9000_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	10 / 11	LEU A 588 VAL A 596 ALA A 614 VAL A 647 THR A 663 TYR A 665 CYH A 666 GLY A 669 LEU A 785 ALA A 800	None	0.49A	3g0eA-2ogvA: 43.3	3g0eA-2ogvA: 67.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G0F_A_B49A9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 11	LEU A 588 VAL A 596 ALA A 614 THR A 663 TYR A 665 CYH A 666 GLY A 669 ASP A 670 LEU A 785	None	0.49A	3g0fA-2ogvA: 38.9	3g0fA-2ogvA: 67.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G0F_B_B49B9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 10	LEU A 588 VAL A 596 ALA A 614 THR A 663 TYR A 665 CYH A 666 GLY A 669 LEU A 785	None	0.42A	3g0fB-2ogvA: 38.2	3g0fB-2ogvA: 67.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G5D_A_1N1A1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	10 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.75A	3g5dA-2ogvA: 29.0	3g5dA-2ogvA: 34.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G5D_B_1N1B1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	10 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.85A	3g5dB-2ogvA: 29.2	3g5dB-2ogvA: 34.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G5D_B_1N1B1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLU A 633 MET A 637 TYR A 665 GLY A 669 LEU A 785	None	0.94A	3g5dB-2ogvA: 29.2	3g5dB-2ogvA: 34.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 GLU A 633 HIS A 776 ASP A 796 PHE A 797	None	1.01A	3gp0A-2ogvA: 21.2	3gp0A-2ogvA: 27.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 GLU A 633 THR A 663 HIS A 776 ASP A 796	None	0.69A	3gp0A-2ogvA: 21.2	3gp0A-2ogvA: 27.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GVU_A_STIA1001_1 (TYROSINE-PROTEIN KINASE ABL2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 LEU A 785 ASP A 796	None	0.87A	3gvuA-2ogvA: 22.0	3gvuA-2ogvA: 37.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K54_A_1N1A1_1 (TYROSINE-PROTEIN KINASE BTK)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	10 / 12	LEU A 588 ALA A 614 LYS A 616 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.83A	3k54A-2ogvA: 20.3	3k54A-2ogvA: 34.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K5V_A_STIA2_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 ASP A 796	None	0.89A	3k5vA-2ogvA: 32.0	3k5vA-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K5V_A_STIA2_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.78A	3k5vA-2ogvA: 32.0	3k5vA-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K5V_B_STIB2_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 ASP A 796	None	0.91A	3k5vB-2ogvA: 22.1	3k5vB-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K5V_B_STIB2_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.80A	3k5vB-2ogvA: 22.1	3k5vB-2ogvA: 38.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_A_TFPA202_1 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	LEU A 910 PHE A 909 ILE A 888 CYH A 892 LEU A 845	None	0.97A	3ko0A-2ogvA: undetectable 3ko0B-2ogvA: undetectable 3ko0C-2ogvA: undetectable 3ko0D-2ogvA: undetectable	3ko0A-2ogvA: 15.41 3ko0B-2ogvA: 15.41 3ko0C-2ogvA: 15.41 3ko0D-2ogvA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_B_TFPB202_2 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 6	LEU A 910 PHE A 909 ILE A 888 CYH A 892	None	0.78A	3ko0B-2ogvA: undetectable	3ko0B-2ogvA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_I_TFPI202_1 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	LEU A 910 PHE A 909 ILE A 888 CYH A 892 LEU A 845	None	0.92A	3ko0G-2ogvA: undetectable 3ko0H-2ogvA: undetectable 3ko0I-2ogvA: undetectable 3ko0J-2ogvA: undetectable	3ko0G-2ogvA: 15.41 3ko0H-2ogvA: 15.41 3ko0I-2ogvA: 15.41 3ko0J-2ogvA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_J_TFPJ202_1 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 11	LEU A 845 LEU A 910 PHE A 909 ILE A 888 CYH A 892	None	0.92A	3ko0A-2ogvA: undetectable 3ko0B-2ogvA: undetectable 3ko0I-2ogvA: undetectable 3ko0J-2ogvA: undetectable	3ko0A-2ogvA: 15.41 3ko0B-2ogvA: 15.41 3ko0I-2ogvA: 15.41 3ko0J-2ogvA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_K_TFPK202_1 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	LEU A 910 PHE A 909 ILE A 888 CYH A 892 LEU A 845	None	0.98A	3ko0K-2ogvA: undetectable 3ko0L-2ogvA: undetectable 3ko0S-2ogvA: undetectable 3ko0T-2ogvA: undetectable	3ko0K-2ogvA: 15.41 3ko0L-2ogvA: 15.41 3ko0S-2ogvA: 15.41 3ko0T-2ogvA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_L_TFPL202_1 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	LEU A 845 LEU A 910 PHE A 909 ILE A 888 CYH A 892	None	0.97A	3ko0K-2ogvA: undetectable 3ko0L-2ogvA: undetectable 3ko0M-2ogvA: undetectable 3ko0N-2ogvA: undetectable	3ko0K-2ogvA: 15.41 3ko0L-2ogvA: 15.41 3ko0M-2ogvA: 15.41 3ko0N-2ogvA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_M_TFPM202_1 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	LEU A 910 PHE A 909 ILE A 888 CYH A 892 LEU A 845	None	1.00A	3ko0M-2ogvA: undetectable 3ko0N-2ogvA: undetectable 3ko0O-2ogvA: undetectable 3ko0P-2ogvA: undetectable	3ko0M-2ogvA: 15.41 3ko0N-2ogvA: 15.41 3ko0O-2ogvA: 15.41 3ko0P-2ogvA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_P_TFPP202_1 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	LEU A 845 LEU A 910 PHE A 909 ILE A 888 CYH A 892	None	0.98A	3ko0M-2ogvA: undetectable 3ko0N-2ogvA: undetectable 3ko0O-2ogvA: undetectable 3ko0P-2ogvA: undetectable	3ko0M-2ogvA: 15.41 3ko0N-2ogvA: 15.41 3ko0O-2ogvA: 15.41 3ko0P-2ogvA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_S_TFPS202_1 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 6	LEU A 910 PHE A 909 ILE A 888 CYH A 892	None	0.78A	3ko0S-2ogvA: undetectable	3ko0S-2ogvA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_S_TFPS202_1 (PROTEIN S100-A4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 6	LEU A 910 SER A 908 PHE A 909 ILE A 888	None	0.91A	3ko0S-2ogvA: undetectable	3ko0S-2ogvA: 15.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 ASP A 796	None	0.91A	3ms9A-2ogvA: 31.9	3ms9A-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 LEU A 785	None	0.87A	3ms9A-2ogvA: 31.9	3ms9A-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 ASP A 796	None	0.92A	3ms9B-2ogvA: 32.4	3ms9B-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.85A	3ms9B-2ogvA: 32.4	3ms9B-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 ASP A 796	None	0.91A	3mssA-2ogvA: 32.1	3mssA-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 LEU A 785	None	0.88A	3mssA-2ogvA: 32.1	3mssA-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.71A	3mssB-2ogvA: 32.1	3mssB-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_C_STIC1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 ASP A 796	None	0.93A	3mssC-2ogvA: 32.1	3mssC-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_C_STIC1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 LEU A 785	None	0.89A	3mssC-2ogvA: 32.1	3mssC-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_D_STID1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 ASP A 796	None	0.94A	3mssD-2ogvA: 32.1	3mssD-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_D_STID1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.87A	3mssD-2ogvA: 32.1	3mssD-2ogvA: 38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OCT_A_1N1A663_1 (TYROSINE-PROTEIN KINASE BTK)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 ALA A 614 LYS A 616 MET A 637 TYR A 665 GLY A 669 LEU A 785	None	0.61A	3octA-2ogvA: 15.2	3octA-2ogvA: 33.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OCT_A_1N1A663_1 (TYROSINE-PROTEIN KINASE BTK)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 ALA A 614 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.70A	3octA-2ogvA: 15.2	3octA-2ogvA: 33.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OCT_A_1N1A663_1 (TYROSINE-PROTEIN KINASE BTK)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 MET A 637 GLY A 669 LEU A 785	None	0.68A	3octA-2ogvA: 15.2	3octA-2ogvA: 33.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OCT_A_1N1A663_1 (TYROSINE-PROTEIN KINASE BTK)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 MET A 637 VAL A 647 THR A 663 GLY A 669 LEU A 785	None	0.71A	3octA-2ogvA: 15.2	3octA-2ogvA: 33.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_A_STIA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 GLY A 669 LEU A 785	None	0.71A	3oezA-2ogvA: 30.0	3oezA-2ogvA: 34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_A_STIA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 ASP A 796	None	0.80A	3oezA-2ogvA: 30.0	3oezA-2ogvA: 34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_A_STIA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 TYR A 665 GLY A 669	None	0.80A	3oezA-2ogvA: 30.0	3oezA-2ogvA: 34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_B_STIB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 TYR A 665 LEU A 785	None	0.82A	3oezB-2ogvA: 29.9	3oezB-2ogvA: 34.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	VAL A 596 ALA A 614 LYS A 616 THR A 663 CYH A 666	None	0.60A	3og7A-2ogvA: 25.2	3og7A-2ogvA: 28.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXZ_A_0LIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 GLY A 669 HIS A 776 ASP A 796	None	0.84A	3oxzA-2ogvA: 21.4	3oxzA-2ogvA: 37.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PYY_A_STIA3_1 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 ASP A 796	None	0.77A	3pyyA-2ogvA: 32.8	3pyyA-2ogvA: 36.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PYY_A_STIA3_1 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.68A	3pyyA-2ogvA: 32.8	3pyyA-2ogvA: 36.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PYY_A_STIA3_1 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663	None	0.75A	3pyyA-2ogvA: 32.8	3pyyA-2ogvA: 36.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PYY_A_STIA3_1 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 GLY A 669	None	0.79A	3pyyA-2ogvA: 32.8	3pyyA-2ogvA: 36.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PYY_B_STIB4_1 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 LEU A 785 ASP A 796	None	0.91A	3pyyB-2ogvA: 30.1	3pyyB-2ogvA: 36.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QLG_A_1N1A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	10 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.86A	3qlgA-2ogvA: 29.8	3qlgA-2ogvA: 34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QLG_B_1N1B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	10 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.82A	3qlgB-2ogvA: 19.7	3qlgB-2ogvA: 34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXR_A_1N1A1_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 MET A 637 VAL A 647 THR A 663 TYR A 665 LEU A 785	None	0.59A	3sxrA-2ogvA: 28.2	3sxrA-2ogvA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXR_A_1N1A1_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.47A	3sxrA-2ogvA: 28.2	3sxrA-2ogvA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXR_B_1N1B2_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 VAL A 596 ALA A 614 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.60A	3sxrB-2ogvA: 27.9	3sxrB-2ogvA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UE4_B_DB8B601_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 GLY A 669 LEU A 785	None	0.92A	3ue4B-2ogvA: 30.4	3ue4B-2ogvA: 35.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UE4_B_DB8B601_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 MET A 637 THR A 663 GLY A 669 LEU A 785	None	0.78A	3ue4B-2ogvA: 30.4	3ue4B-2ogvA: 35.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UE4_B_DB8B601_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 GLY A 669 LEU A 785	None	0.87A	3ue4B-2ogvA: 30.4	3ue4B-2ogvA: 35.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UE4_B_DB8B601_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 MET A 637 VAL A 647 THR A 663 GLY A 669 LEU A 785	None	0.68A	3ue4B-2ogvA: 30.4	3ue4B-2ogvA: 35.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 CYH A 666 GLY A 669	None	0.58A	3wzdA-2ogvA: 33.3	3wzdA-2ogvA: 50.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZE_A_BAXA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLU A 633 GLY A 669 LEU A 769 HIS A 776	None	0.63A	3wzeA-2ogvA: 39.6	3wzeA-2ogvA: 50.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZE_A_BAXA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 8	VAL A 647 CYH A 666 LEU A 785 ILE A 794 ASP A 796	None	0.63A	3wzeA-2ogvA: 39.6	3wzeA-2ogvA: 50.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	ALA A 614 GLY A 669 ASP A 670 LEU A 785 GLY A 795	None	0.51A	3zbfA-2ogvA: 29.9	3zbfA-2ogvA: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_A_0LIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 ALA A 614 LYS A 616 GLU A 633 THR A 663 HIS A 776 ARG A 777 LEU A 785 ASP A 796	None	1.00A	3zosA-2ogvA: 32.5	3zosA-2ogvA: 35.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_A_0LIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 ALA A 614 LYS A 616 GLU A 633 THR A 663 LEU A 769 HIS A 776 LEU A 785 ASP A 796	None	0.84A	3zosA-2ogvA: 32.5	3zosA-2ogvA: 35.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 9	ILE A 636 MET A 637 ILE A 646 TYR A 665 ILE A 794	None	0.93A	3zosA-2ogvA: 32.5	3zosA-2ogvA: 35.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_B_0LIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	ALA A 614 LYS A 616 GLU A 633 THR A 663 HIS A 776 ARG A 777 LEU A 785 ASP A 796	None	1.07A	3zosB-2ogvA: 32.8	3zosB-2ogvA: 35.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_B_0LIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	ALA A 614 LYS A 616 GLU A 633 THR A 663 LEU A 769 HIS A 776 LEU A 785 ASP A 796	None	0.88A	3zosB-2ogvA: 32.8	3zosB-2ogvA: 35.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_B_0LIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 9	LEU A 588 ILE A 636 MET A 637 ILE A 646 TYR A 665 ILE A 794	None	0.97A	3zosB-2ogvA: 32.8	3zosB-2ogvA: 35.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A3U_A_NCAA1359_0 (NADH:FLAVIN OXIDOREDUCTASE/NADH OXIDASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 7	TRP A 550 HIS A 776 ASN A 783 TYR A 546	None	1.41A	4a3uA-2ogvA: undetectable	4a3uA-2ogvA: 20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A3U_B_NCAB1359_0 (NADH:FLAVIN OXIDOREDUCTASE/NADH OXIDASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 7	TRP A 550 HIS A 776 ASN A 783 TYR A 546	None	1.47A	4a3uB-2ogvA: undetectable	4a3uB-2ogvA: 20.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4AG8_A_AXIA2000_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLU A 633 VAL A 647 GLY A 669 LEU A 785	None	0.58A	4ag8A-2ogvA: 27.1	4ag8A-2ogvA: 50.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4AGC_A_AXIA2000_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 GLY A 669 LEU A 785	None	0.50A	4agcA-2ogvA: 41.0	4agcA-2ogvA: 48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4AGC_A_AXIA2000_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLU A 633 GLY A 669	None	0.53A	4agcA-2ogvA: 41.0	4agcA-2ogvA: 48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4AGD_A_B49A2000_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 11	LEU A 588 ALA A 614 LYS A 616 VAL A 647 CYH A 666 GLY A 669 LEU A 785	None	0.48A	4agdA-2ogvA: 27.4	4agdA-2ogvA: 48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ASD_A_BAXA1500_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLU A 633 GLY A 669 LEU A 769 HIS A 776	None	0.63A	4asdA-2ogvA: 39.9	4asdA-2ogvA: 48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ASD_A_BAXA1500_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 LYS A 616 GLU A 633 GLY A 669 LEU A 769 HIS A 776 PHE A 797	None	0.84A	4asdA-2ogvA: 39.9	4asdA-2ogvA: 48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ASD_A_BAXA1500_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 6	VAL A 647 CYH A 666 LEU A 785 ILE A 794	None	0.49A	4asdA-2ogvA: 39.9	4asdA-2ogvA: 48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 ILE A 636 MET A 637 THR A 663 TYR A 665 LEU A 785	None	1.10A	4bkjA-2ogvA: 31.5	4bkjA-2ogvA: 35.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 GLU A 633 ILE A 636 MET A 637 THR A 663 TYR A 665 ASP A 796	None	0.94A	4bkjA-2ogvA: 31.5	4bkjA-2ogvA: 35.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 ILE A 636 MET A 637 THR A 663 LEU A 785	None	0.94A	4bkjB-2ogvA: 31.6	4bkjB-2ogvA: 35.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 ILE A 636 MET A 637 THR A 663 ASP A 796	None	0.97A	4bkjB-2ogvA: 31.6	4bkjB-2ogvA: 35.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 LYS A 616 GLU A 633 THR A 663 HIS A 776 LEU A 785 ASP A 796	None	0.78A	4c8bA-2ogvA: 25.9	4c8bA-2ogvA: 26.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 5	VAL A 596 ILE A 646 TYR A 665 ILE A 794	None	0.72A	4c8bA-2ogvA: 25.9	4c8bA-2ogvA: 26.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 ILE A 646 THR A 663 HIS A 776 LEU A 785 ASP A 796	None	0.86A	4c8bB-2ogvA: 25.2	4c8bB-2ogvA: 26.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CKI_A_ADNA2022_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 11	LEU A 588 GLY A 589 VAL A 596 ALA A 614 TYR A 665 GLY A 669 LEU A 785	None	0.43A	4ckiA-2ogvA: 30.8	4ckiA-2ogvA: 43.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CKJ_A_ADNA2014_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 10	LEU A 588 GLY A 589 GLY A 591 VAL A 596 ALA A 614 TYR A 665 LEU A 785	None	0.42A	4ckjA-2ogvA: 31.5	4ckjA-2ogvA: 43.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 ASP A 796 PHE A 797	None	1.00A	4csvA-2ogvA: 30.8	4csvA-2ogvA: 38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	VAL A 596 ALA A 614 GLU A 633 ILE A 636 MET A 637 VAL A 647 THR A 663 TYR A 665 ASP A 796	None	0.76A	4csvA-2ogvA: 30.8	4csvA-2ogvA: 38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	VAL A 596 ALA A 614 GLU A 633 ILE A 636 MET A 637 VAL A 647 THR A 663 TYR A 665 LEU A 785	None	0.74A	4csvA-2ogvA: 30.8	4csvA-2ogvA: 38.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IIZ_B_LURB201_1 (TRANSTHYRETIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 8	LEU A 649 THR A 654 ALA A 652 VAL A 659	None	0.94A	4iizB-2ogvA: undetectable	4iizB-2ogvA: 19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IK6_B_LURB201_1 (TRANSTHYRETIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 8	LEU A 649 THR A 654 ALA A 652 VAL A 659	None	0.97A	4ik6B-2ogvA: undetectable	4ik6B-2ogvA: 19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 7	VAL A 596 ALA A 614 ASP A 670 LEU A 785	None	0.56A	4l9iA-2ogvA: 7.1	4l9iA-2ogvA: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_B_8PRB601_1 (RHODOPSIN KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 8	VAL A 596 ALA A 614 LYS A 616 ASP A 670 LEU A 785	None	0.77A	4l9iB-2ogvA: 20.9	4l9iB-2ogvA: 21.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLY A 669 ASP A 670 LEU A 785	None	0.52A	4mkcA-2ogvA: 30.6	4mkcA-2ogvA: 33.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLY A 669 LEU A 785 ASP A 796	None	0.70A	4mkcA-2ogvA: 30.6	4mkcA-2ogvA: 33.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXO_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.74A	4mxoB-2ogvA: 29.4	4mxoB-2ogvA: 34.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 LEU A 785	None	0.76A	4mxxA-2ogvA: 29.0	4mxxA-2ogvA: 34.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.69A	4mxxA-2ogvA: 29.0	4mxxA-2ogvA: 34.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.84A	4mxxB-2ogvA: 21.0	4mxxB-2ogvA: 34.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.75A	4mxxB-2ogvA: 21.0	4mxxB-2ogvA: 34.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXY_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 GLU A 633 VAL A 647 TYR A 665 GLY A 669 LEU A 785 ASP A 796	None	0.96A	4mxyA-2ogvA: 29.4	4mxyA-2ogvA: 34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXY_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 VAL A 647 TYR A 665 GLY A 669 LEU A 785 ASP A 796	None	0.88A	4mxyB-2ogvA: 21.4	4mxyB-2ogvA: 34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXZ_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 GLU A 633 VAL A 647 TYR A 665 GLY A 669 LEU A 785 ASP A 796	None	0.96A	4mxzA-2ogvA: 29.4	4mxzA-2ogvA: 34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXZ_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 VAL A 647 TYR A 665 GLY A 669 LEU A 785 ASP A 796	None	0.88A	4mxzB-2ogvA: 21.4	4mxzB-2ogvA: 34.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0S_A_ADNA500_1 (AURORA KINASE A)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 11	LEU A 588 GLY A 589 VAL A 596 ALA A 614 LYS A 616 ASN A 783 LEU A 785	None	0.54A	4o0sA-2ogvA: 23.3	4o0sA-2ogvA: 26.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0U_A_ADNA501_1 (AURORA KINASE A)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 6	VAL A 596 ALA A 614 LYS A 616 LEU A 785	None	0.52A	4o0uA-2ogvA: 16.1	4o0uA-2ogvA: 25.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0W_A_ADNA501_1 (AURORA KINASE A)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 6	LEU A 588 GLY A 589 VAL A 596 ALA A 614 LEU A 785	None	0.50A	4o0wA-2ogvA: 16.9	4o0wA-2ogvA: 25.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_E_ADNE401_1 (CYCLIN-DEPENDENT KINASE 9)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 7	ALA A 614 CYH A 666 ASP A 670 ASN A 783 LEU A 785	None	0.73A	4ogrE-2ogvA: 21.1	4ogrE-2ogvA: 26.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_E_ADNE401_1 (CYCLIN-DEPENDENT KINASE 9)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 7	CYH A 666 ASP A 670 ASN A 783 LEU A 785 ASP A 796	None	0.69A	4ogrE-2ogvA: 21.1	4ogrE-2ogvA: 26.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_E_ADNE401_1 (CYCLIN-DEPENDENT KINASE 9)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 7	GLY A 589 ALA A 614 CYH A 666 ASP A 670 LEU A 785	None	0.84A	4ogrE-2ogvA: 21.1	4ogrE-2ogvA: 26.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 9	VAL A 596 ALA A 614 CYH A 666 ASP A 670 ASN A 783 LEU A 785	None	0.75A	4ogrI-2ogvA: 21.2	4ogrI-2ogvA: 26.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTW_A_DB8A1101_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785 VAL A 548	None	1.10A	4otwA-2ogvA: 22.5	4otwA-2ogvA: 29.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QRC_A_0LIA802_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 LEU A 769 CYH A 774 ARG A 777	None	0.69A	4qrcA-2ogvA: 33.3	4qrcA-2ogvA: 45.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QRC_A_0LIA802_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 8	LEU A 588 VAL A 596 HIS A 776 LEU A 785	None	0.62A	4qrcA-2ogvA: 33.3	4qrcA-2ogvA: 45.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R7I_A_STIA1001_1 (MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LYS A 616 GLU A 633 MET A 637 THR A 663 CYH A 774 GLY A 795 ASP A 796 PHE A 797	None	0.96A	4r7iA-2ogvA: 29.1	4r7iA-2ogvA: 95.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R7I_A_STIA1001_1 (MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	11 / 12	VAL A 596 ALA A 614 LYS A 616 GLU A 633 MET A 637 THR A 663 CYH A 666 CYH A 774 LEU A 785 GLY A 795 ASP A 796	None	0.66A	4r7iA-2ogvA: 29.1	4r7iA-2ogvA: 95.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R7I_A_STIA1001_2 (MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 5	LEU A 588 VAL A 647 VAL A 661 TYR A 665 ARG A 777	None	0.50A	4r7iA-2ogvA: 29.1	4r7iA-2ogvA: 95.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZV_B_032B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 LYS A 616 THR A 663 CYH A 666 GLY A 795	None	0.75A	4rzvB-2ogvA: 18.4	4rzvB-2ogvA: 28.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TYJ_A_0LIA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 MET A 637 CYH A 774 HIS A 776 LEU A 785 ASP A 796	None	0.77A	4tyjA-2ogvA: 33.1	4tyjA-2ogvA: 45.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U0I_A_0LIA1001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 10	LEU A 588 VAL A 596 GLU A 633 ILE A 646 VAL A 647 VAL A 661 TYR A 665 ARG A 777 ILE A 794	None	0.85A	4u0iA-2ogvA: 39.8	4u0iA-2ogvA: 67.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U0I_A_0LIA1001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 10	LEU A 588 VAL A 596 GLU A 633 LEU A 640 ILE A 646 VAL A 661 TYR A 665 ARG A 777	None	0.79A	4u0iA-2ogvA: 39.8	4u0iA-2ogvA: 67.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U0I_A_0LIA1001_2 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	ALA A 614 LYS A 616 THR A 663 CYH A 666 GLY A 669 CYH A 774 HIS A 776 LEU A 785 ASP A 796	None	0.74A	4u0iA-2ogvA: 39.8	4u0iA-2ogvA: 67.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U5J_A_RXTA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 11	LEU A 588 VAL A 596 ALA A 614 TYR A 665 GLY A 669 ASN A 783 LEU A 785 ASP A 796	None	0.56A	4u5jA-2ogvA: 30.0	4u5jA-2ogvA: 34.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U5J_B_RXTB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 9	LEU A 588 VAL A 596 ALA A 614 TYR A 665 GLY A 669 LEU A 785 ASP A 796	None	0.71A	4u5jB-2ogvA: 29.4	4u5jB-2ogvA: 34.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4UXQ_A_0LIA1752_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 ALA A 614 GLU A 633 LEU A 769 CYH A 774 HIS A 776 LEU A 785	None	0.59A	4uxqA-2ogvA: 33.5	4uxqA-2ogvA: 45.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 LEU A 769 HIS A 776 ASP A 796	None	0.82A	4v01A-2ogvA: 32.9	4v01A-2ogvA: 47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 9	LEU A 588 VAL A 596 TYR A 665 CYH A 774 ARG A 777 LEU A 785 ILE A 794	None	0.87A	4v01A-2ogvA: 32.9	4v01A-2ogvA: 47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 LEU A 769 CYH A 774 HIS A 776	None	0.53A	4v01B-2ogvA: 32.8	4v01B-2ogvA: 47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 LEU A 769 HIS A 776 ASP A 796	None	0.73A	4v01B-2ogvA: 32.8	4v01B-2ogvA: 47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 9	LEU A 588 VAL A 596 LYS A 616 TYR A 665 ARG A 777 LEU A 785 ILE A 794	None	0.84A	4v01B-2ogvA: 32.8	4v01B-2ogvA: 47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 GLU A 633 LEU A 769 CYH A 774 HIS A 776	None	0.60A	4v04A-2ogvA: 33.1	4v04A-2ogvA: 47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 8	MET A 637 TYR A 665 ARG A 777 LEU A 785 ILE A 794	None	1.10A	4v04A-2ogvA: 33.1	4v04A-2ogvA: 47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 10	LEU A 588 VAL A 596 MET A 637 TYR A 665 ARG A 777 LEU A 785 ILE A 794	None	0.97A	4v04B-2ogvA: 33.1	4v04B-2ogvA: 47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	ALA A 614 GLU A 633 LEU A 769 HIS A 776 ASP A 796	None	0.81A	4v04B-2ogvA: 33.1	4v04B-2ogvA: 47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WA9_A_AXIA9000_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 11	LEU A 588 ALA A 614 THR A 663 GLY A 669 ASN A 783 LEU A 785	None	0.78A	4wa9A-2ogvA: 26.0	4wa9A-2ogvA: 37.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XEY_A_1N1A601_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 MET A 637 GLY A 669 LEU A 785	None	0.78A	4xeyA-2ogvA: 30.4	4xeyA-2ogvA: 31.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XEY_A_1N1A601_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 MET A 637 VAL A 647 THR A 663 GLY A 669 LEU A 785	None	0.72A	4xeyA-2ogvA: 30.4	4xeyA-2ogvA: 31.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XEY_B_1N1B601_1 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 MET A 637 VAL A 647 THR A 663 GLY A 669 LEU A 785	None	0.59A	4xeyB-2ogvA: 29.7	4xeyB-2ogvA: 31.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_A_1N1A601_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.82A	4xliA-2ogvA: 30.4	4xliA-2ogvA: 39.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_B_1N1B600_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.85A	4xliB-2ogvA: 29.9	4xliB-2ogvA: 39.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 LYS A 616 THR A 663 CYH A 666 GLY A 795	None	0.54A	4xv2A-2ogvA: 25.1	4xv2A-2ogvA: 28.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 LYS A 616 THR A 663 CYH A 666 GLY A 795 ASP A 796	None	0.90A	4xv2B-2ogvA: 25.6	4xv2B-2ogvA: 28.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAA_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 9	LEU A 588 VAL A 596 ALA A 614 GLY A 669 LEU A 785 GLY A 795 ASP A 796	None	0.79A	5aaaA-2ogvA: 30.9	5aaaA-2ogvA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAB_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 10	LEU A 588 VAL A 596 ALA A 614 GLY A 669 LEU A 785 GLY A 795 ASP A 796	None	0.81A	5aabA-2ogvA: 30.7	5aabA-2ogvA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAC_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 10	LEU A 588 VAL A 596 ALA A 614 GLY A 669 LEU A 785 GLY A 795 ASP A 796	None	0.78A	5aacA-2ogvA: 30.5	5aacA-2ogvA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAC_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 10	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLY A 669 LEU A 785 ASP A 796	None	1.01A	5aacA-2ogvA: 30.5	5aacA-2ogvA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AJQ_A_DB8A800_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 GLY A 589 ALA A 614 CYH A 666 GLY A 669 LEU A 785	None	0.74A	5ajqA-2ogvA: 21.2	5ajqA-2ogvA: 32.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AJQ_B_DB8B800_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 10	ALA A 614 CYH A 666 GLY A 669 LEU A 785 ASP A 796	None	0.61A	5ajqB-2ogvA: 15.5	5ajqB-2ogvA: 32.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5BVW_A_1N1A1009_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.87A	5bvwA-2ogvA: 31.9	5bvwA-2ogvA: 34.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5BVW_A_1N1A1009_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 GLU A 633 MET A 637 TYR A 665 GLY A 669	None	0.89A	5bvwA-2ogvA: 31.9	5bvwA-2ogvA: 34.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 LYS A 616 THR A 663 CYH A 666 GLY A 795	None	0.54A	5cswA-2ogvA: 17.1	5cswA-2ogvA: 28.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 LYS A 616 THR A 663 CYH A 666 GLY A 795	None	0.48A	5cswB-2ogvA: 24.9	5cswB-2ogvA: 28.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_A_1N1A501_1 (PROTEIN-TYROSINE KINASE 6)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 THR A 663 GLY A 669 LEU A 785 GLY A 795	None	0.82A	5h2uA-2ogvA: 27.4	5h2uA-2ogvA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_B_1N1B501_1 (PROTEIN-TYROSINE KINASE 6)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 LYS A 616 THR A 663 LEU A 785 GLY A 795	None	0.87A	5h2uB-2ogvA: 27.7	5h2uB-2ogvA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_B_1N1B501_1 (PROTEIN-TYROSINE KINASE 6)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 THR A 663 GLY A 669 LEU A 785 GLY A 795	None	0.70A	5h2uB-2ogvA: 27.7	5h2uB-2ogvA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_C_1N1C501_1 (PROTEIN-TYROSINE KINASE 6)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 ALA A 614 LYS A 616 GLY A 669 LEU A 785 GLY A 795	None	0.68A	5h2uC-2ogvA: 27.3	5h2uC-2ogvA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_C_1N1C501_1 (PROTEIN-TYROSINE KINASE 6)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 ALA A 614 THR A 663 GLY A 669 LEU A 785 GLY A 795	None	0.70A	5h2uC-2ogvA: 27.3	5h2uC-2ogvA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_D_1N1D504_1 (PROTEIN-TYROSINE KINASE 6)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 ALA A 614 THR A 663 GLY A 669 LEU A 785 GLY A 795	None	0.64A	5h2uD-2ogvA: 22.4	5h2uD-2ogvA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_D_1N1D504_1 (PROTEIN-TYROSINE KINASE 6)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 VAL A 596 ALA A 614 GLY A 669 LEU A 785 GLY A 795	None	0.51A	5h2uD-2ogvA: 22.4	5h2uD-2ogvA: 35.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HI2_A_BAXA801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 GLU A 633 THR A 663 CYH A 666 LEU A 769 HIS A 776 GLY A 795	None	0.49A	5hi2A-2ogvA: 26.7	5hi2A-2ogvA: 28.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HI2_A_BAXA801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	ALA A 614 LYS A 616 GLU A 633 THR A 663 LEU A 769 HIS A 776 GLY A 795	None	0.73A	5hi2A-2ogvA: 26.7	5hi2A-2ogvA: 28.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	GLY A 798 VAL A 596 ALA A 614 LYS A 616 LEU A 634 THR A 663	None	1.16A	5hieA-2ogvA: 24.1	5hieA-2ogvA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	GLY A 798 VAL A 596 ALA A 614 LYS A 616 THR A 663 GLY A 795	None	0.72A	5hieA-2ogvA: 24.1	5hieA-2ogvA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	GLY A 798 VAL A 596 ALA A 614 LYS A 616 THR A 663 GLY A 795	None	0.71A	5hieB-2ogvA: 24.1	5hieB-2ogvA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_C_P06C801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	GLY A 589 VAL A 596 ALA A 614 LYS A 616 THR A 663 GLY A 795	None	0.71A	5hieC-2ogvA: 18.6	5hieC-2ogvA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_C_P06C801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	GLY A 798 ALA A 614 LYS A 616 THR A 663 GLY A 795 ASP A 796	None	1.07A	5hieC-2ogvA: 18.6	5hieC-2ogvA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_C_P06C801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	GLY A 798 VAL A 596 ALA A 614 LYS A 616 THR A 663 GLY A 795	None	0.72A	5hieC-2ogvA: 18.6	5hieC-2ogvA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_D_P06D801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	GLY A 798 VAL A 596 ALA A 614 LYS A 616 THR A 663 GLY A 795	None	0.72A	5hieD-2ogvA: 24.3	5hieD-2ogvA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I8F_A_ML1A211_1 (PHENOLIC OXIDATIVE COUPLING PROTEIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 6	VAL A 784 ALA A 792 GLN A 761 VAL A 762	None	1.02A	5i8fA-2ogvA: undetectable	5i8fA-2ogvA: 22.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5I9Y_A_1N1A1001_1 (EPHRIN TYPE-A RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 LYS A 616 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.62A	5i9yA-2ogvA: 22.3	5i9yA-2ogvA: 35.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 7	GLY A 589 GLY A 591 GLY A 594 VAL A 596	None	0.22A	5izjB-2ogvA: 21.1	5izjB-2ogvA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	GLY A 589 VAL A 596 ALA A 614 VAL A 647 ASP A 670 LEU A 785	None	0.56A	5l2iA-2ogvA: 8.1	5l2iA-2ogvA: 23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LVN_A_ADNA402_1 (3-PHOSPHOINOSITIDE-D EPENDENT PROTEIN KINASE 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 11	LEU A 588 GLY A 589 VAL A 596 ALA A 614 VAL A 647 TYR A 665 LEU A 785	None	0.48A	5lvnA-2ogvA: 15.1	5lvnA-2ogvA: 24.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MAF_A_XINA403_1 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	GLY A 589 VAL A 596 ALA A 614 LYS A 616 GLU A 633 TYR A 665 GLY A 669	None	0.75A	5mafA-2ogvA: 22.1	5mafA-2ogvA: 13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_2 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	ALA A 614 MET A 637 VAL A 647 HIS A 776 LEU A 785	None	0.77A	5mo4A-2ogvA: 25.5	5mo4A-2ogvA: 26.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N3H_A_NCAA401_0 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 10	LEU A 588 VAL A 596 ALA A 614 VAL A 647 TYR A 665 LEU A 785	None	0.71A	5n3hA-2ogvA: 20.8	5n3hA-2ogvA: 24.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OWR_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 8	ALA A 614 GLU A 633 CYH A 666 LEU A 785	None	0.63A	5owrA-2ogvA: 19.3	5owrA-2ogvA: 32.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5P9I_A_1E8A701_1 (TYROSINE-PROTEIN KINASE BTK)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	GLY A 589 VAL A 596 ALA A 614 THR A 663 GLY A 669 ASN A 673 LEU A 785	None	1.44A	5p9iA-2ogvA: 28.7	5p9iA-2ogvA: 33.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5P9I_A_1E8A701_1 (TYROSINE-PROTEIN KINASE BTK)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	VAL A 596 ALA A 614 LYS A 616 THR A 663 GLY A 669 LEU A 785	None	0.73A	5p9iA-2ogvA: 28.7	5p9iA-2ogvA: 33.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TE0_A_XINA401_1 (AP2-ASSOCIATED PROTEIN KINASE 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	ALA A 614 GLU A 633 MET A 637 VAL A 647 GLY A 669 LEU A 785	None	0.69A	5te0A-2ogvA: 21.9	5te0A-2ogvA: 21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	GLY A 589 ALA A 614 GLU A 633 TYR A 665 CYH A 666 GLY A 669 ASP A 796	None	0.96A	5vc3A-2ogvA: 15.5	5vc3A-2ogvA: 24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	GLY A 589 ALA A 614 TYR A 665 CYH A 666 GLY A 669 ASP A 670	None	1.17A	5vc3A-2ogvA: 15.5	5vc3A-2ogvA: 24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCV_A_1N1A404_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 ALA A 614 GLU A 633 VAL A 647 THR A 663 GLY A 669 GLY A 795	None	1.03A	5vcvA-2ogvA: 22.0	5vcvA-2ogvA: 26.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 THR A 663 CYH A 666	None	0.68A	5vcyA-2ogvA: 21.7	5vcyA-2ogvA: 26.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W5V_A_ANWA701_0 (SERINE/THREONINE-PRO TEIN KINASE TBK1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 9	LEU A 588 ALA A 614 VAL A 647 CYH A 666 GLY A 669	None	0.41A	5w5vA-2ogvA: 8.6	5w5vA-2ogvA: 18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7Z_A_IREA401_0 (CYCLIN-G-ASSOCIATED KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 CYH A 666 GLY A 669 LEU A 785	None	0.66A	5y7zA-2ogvA: 21.4	5y7zA-2ogvA: 11.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7Z_A_IREA401_0 (CYCLIN-G-ASSOCIATED KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 CYH A 666 GLY A 669 LEU A 785	None	0.66A	5y7zA-2ogvA: 21.4	5y7zA-2ogvA: 26.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7Z_B_IREB401_0 (CYCLIN-G-ASSOCIATED KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 ALA A 614 GLU A 633 CYH A 666 GLY A 669 LEU A 785 ASP A 796	None	0.99A	5y7zB-2ogvA: 21.4	5y7zB-2ogvA: 11.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y80_A_IREA401_0 (CYCLIN-G-ASSOCIATED KINASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	9 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 THR A 663 CYH A 666 GLY A 669 LEU A 785 ASP A 796	None	0.86A	5y80A-2ogvA: 21.2	5y80A-2ogvA: 11.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 GLY A 589 ALA A 614 GLU A 633 MET A 637 TYR A 665 GLY A 669	None	0.96A	5zv2A-2ogvA: 32.5	5zv2A-2ogvA: 24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 TYR A 665 GLY A 669	None	0.58A	5zv2A-2ogvA: 32.5	5zv2A-2ogvA: 24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 GLY A 669	None	0.57A	5zv2B-2ogvA: 32.2	5zv2B-2ogvA: 24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A4I_A_TRPA403_0 (TRYPTOPHAN 2,3-DIOXYGENASE)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 8	ARG A 549 ARG A 777 ILE A 564 PRO A 566	None	1.01A	6a4iA-2ogvA: undetectable	6a4iA-2ogvA: 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AYC_A_1YNA502_2 (PROTEIN CYP51)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 7	LEU A 752 PHE A 880 PHE A 674 LEU A 750	None	1.12A	6aycA-2ogvA: undetectable	6aycA-2ogvA: 13.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA607_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 4	GLY A 795 ARG A 801 ASN A 783 LEU A 785	None	1.10A	6b58A-2ogvA: undetectable	6b58A-2ogvA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BSD_A_1N1A901_0 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 THR A 663 TYR A 665 GLY A 669 LEU A 785	None	0.84A	6bsdA-2ogvA: 31.7	6bsdA-2ogvA: 13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_A_STIA604_0 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 ASP A 796	None	0.93A	6hd4A-2ogvA: 22.1	6hd4A-2ogvA: 14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_A_STIA604_0 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 LEU A 785	None	0.86A	6hd4A-2ogvA: 22.1	6hd4A-2ogvA: 14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_B_STIB602_0 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 ASP A 796	None	0.91A	6hd4B-2ogvA: 22.2	6hd4B-2ogvA: 14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_B_STIB602_0 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 LEU A 785	None	0.83A	6hd4B-2ogvA: 22.2	6hd4B-2ogvA: 14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_A_STIA603_0 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 ASP A 796	None	0.87A	6hd6A-2ogvA: 31.9	6hd6A-2ogvA: 14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_A_STIA603_0 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 LEU A 785	None	0.82A	6hd6A-2ogvA: 31.9	6hd6A-2ogvA: 14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_B_STIB601_0 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 ASP A 796	None	0.89A	6hd6B-2ogvA: 22.0	6hd6B-2ogvA: 14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_B_STIB601_0 (TYROSINE-PROTEIN KINASE ABL1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	8 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 VAL A 647 THR A 663 LEU A 785	None	0.89A	6hd6B-2ogvA: 22.0	6hd6B-2ogvA: 14.97